• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标准前腹膜切开术与小后切口在 PRESERFLO 微分流植入术中的应用比较。

Standard anterior peritomy versus a small posterior incision for the implantation of the PRESERFLO microshunt.

机构信息

Department of Ophthalmology, University of Würzburg, Würzburg, Germany.

Artemis Eye Centers of Frankfurt, Hanauer Landstr. 147, 60314, Frankfurt, Germany.

出版信息

Int Ophthalmol. 2023 Dec;43(12):5071-5078. doi: 10.1007/s10792-023-02910-z. Epub 2023 Oct 24.

DOI:10.1007/s10792-023-02910-z
PMID:37874441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10724329/
Abstract

PURPOSE

To compare two approaches for the implantation of the PRESERFLO microshunt: an anterior approach (A) with a 6-8-mm peritomy and a posterior approach (P) with a 3-mm incision.

METHODS

We retrospectively analyzed 126 patients who received a PRESERFLO microshunt. We compared intraocular pressure (IOP), surgical time, medication count, and postoperative complications over nine months.

RESULTS

The baseline IOP was similar in A (21.8 ± 8.5 mm Hg) and P (23.9 ± 8.1 mm Hg) (p = 0.08). Surgical duration was significantly shorter in P (10 ± 0.4 min) than in A (26 ± 0.8 min) (p < 0.001). Postoperative IOP levels were comparable in A (10.8 ± 5.9 mm Hg) and P (10.6 ± 4.5 mm Hg) at 30 days (p = 0.62) and throughout the study (all intra-group p-values > 0.08). The preoperative medication count was 3.2 ± 1.3 drops in A and 3.3 ± 1.0 drops in P (p = 0.4). Postoperative values were 0.2 ± 0.6 in A and 0.3 ± 0.7 in P at nine months. There were no significant differences in complications and surgical revisions between groups (p-values > 0.05).

CONCLUSION

Both techniques achieved satisfactory IOP and medication count reductions and had similar safety profiles, but the posterior incision technique was 2.6 times faster than the anterior incision technique.

摘要

目的

比较 PRESERFLO 微分流管植入的两种方法:前入路(A)行 6-8mm 切开,后入路(P)行 3mm 切口。

方法

我们回顾性分析了 126 例接受 PRESERFLO 微分流管植入的患者。我们比较了 9 个月内的眼压(IOP)、手术时间、用药次数和术后并发症。

结果

A 组(21.8±8.5mmHg)和 P 组(23.9±8.1mmHg)的基线 IOP 相似(p=0.08)。P 组的手术时间明显短于 A 组(10±0.4min 比 26±0.8min)(p<0.001)。A 组和 P 组术后 30 天(p=0.62)和整个研究期间(组内所有 p 值均>0.08)的术后 IOP 水平相当。A 组术前用药次数为 3.2±1.3 滴,P 组为 3.3±1.0 滴(p=0.4)。A 组术后 9 个月时为 0.2±0.6 滴,P 组为 0.3±0.7 滴。两组间并发症和手术修订无显著差异(p 值均>0.05)。

结论

两种技术均能达到满意的 IOP 和用药次数减少,且安全性相似,但后入路切口技术比前入路切口技术快 2.6 倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1055/10724329/ed98abe8c8bf/10792_2023_2910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1055/10724329/0f7de1c5ba09/10792_2023_2910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1055/10724329/ed98abe8c8bf/10792_2023_2910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1055/10724329/0f7de1c5ba09/10792_2023_2910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1055/10724329/ed98abe8c8bf/10792_2023_2910_Fig2_HTML.jpg

相似文献

1
Standard anterior peritomy versus a small posterior incision for the implantation of the PRESERFLO microshunt.标准前腹膜切开术与小后切口在 PRESERFLO 微分流植入术中的应用比较。
Int Ophthalmol. 2023 Dec;43(12):5071-5078. doi: 10.1007/s10792-023-02910-z. Epub 2023 Oct 24.
2
Single versus Double PreserFlo MicroShunt Implantation in Glaucoma Patients: A Retrospective Cohort Study.青光眼患者单通道与双通道 PreserFlo 微分流植入术:一项回顾性队列研究。
Ophthalmic Res. 2023;66(1):1362-1375. doi: 10.1159/000535276. Epub 2023 Nov 16.
3
Retrospective Analysis of 12 Months Glaucoma Implant Efficacy: XEN45 and PreserFlo Microshunt.回顾性分析 12 个月青光眼植入物疗效:XEN45 和 PreserFlo 微分流器。
Klin Monbl Augenheilkd. 2022 Apr;239(4):429-434. doi: 10.1055/a-1766-6444. Epub 2022 Apr 26.
4
A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.抗凝血治疗的青光眼患者行 PreserFlo 微导管植入术后迟发性出血性脉络膜脱离 1 例
J Glaucoma. 2020 Aug;29(8):e87-e90. doi: 10.1097/IJG.0000000000001584.
5
Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony.术中初次部分阻断 PreserFlo 微分流管以预防术后早期低眼压。
Int Ophthalmol. 2023 Aug;43(8):2643-2651. doi: 10.1007/s10792-023-02664-8. Epub 2023 Mar 11.
6
Changes to Corneal Topography and Biometrics After PRESERFLO Microshunt Surgery for Glaucoma.青光眼 PRESERFLO 微分流手术对角膜地形和生物测量的影响。
J Glaucoma. 2021 Oct 1;30(10):921-931. doi: 10.1097/IJG.0000000000001912.
7
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.青光眼患者中 PreserFlo 微分流管失败后的开放式滤过泡修复手术的结果。
J Glaucoma. 2023 Aug 1;32(8):681-685. doi: 10.1097/IJG.0000000000002246. Epub 2023 Jun 14.
8
One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.Preserflo微分流器植入治疗难治性青光眼的一年结果
J Glaucoma. 2023 May 1;32(5):414-419. doi: 10.1097/IJG.0000000000002178. Epub 2023 Feb 3.
9
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.外引流微管植入术与小梁切除术治疗原发性开角型青光眼:一项为期 2 年的随机、多中心研究的 1 年结果。
Ophthalmology. 2021 Dec;128(12):1710-1721. doi: 10.1016/j.ophtha.2021.05.023. Epub 2021 May 27.
10
Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study.单中心非随机研究中PRESERFLO微型分流器治疗原发性开角型青光眼患者的长期结果
J Glaucoma. 2021 Mar 1;30(3):281-286. doi: 10.1097/IJG.0000000000001734.

引用本文的文献

1
Management practices and surgical techniques for ab externo less invasive glaucoma surgery: a literature review and expert recommendations.外路微创青光眼手术的管理实践与手术技术:文献综述及专家建议
Graefes Arch Clin Exp Ophthalmol. 2025 May 8. doi: 10.1007/s00417-025-06843-4.

本文引用的文献

1
Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature.PRESERFLO 微型分流器的疗效及文献荟萃分析
J Clin Med. 2022 Dec 1;11(23):7149. doi: 10.3390/jcm11237149.
2
Safety and Efficacy of the Preserflo Microshunt in Refractory Glaucoma: A One-Year Study.Preserflo微分流器治疗难治性青光眼的安全性和有效性:一项为期一年的研究。
J Clin Med. 2022 Nov 29;11(23):7086. doi: 10.3390/jcm11237086.
3
Anterior Segment-Optical Coherence Tomography Bleb Morphology Comparison in Minimally Invasive Glaucoma Surgery: XEN Gel Stent vs. PreserFlo MicroShunt.
微创青光眼手术中眼前节光学相干断层扫描房水引流泡形态比较:XEN凝胶支架与PreserFlo微型分流器
Diagnostics (Basel). 2022 May 17;12(5):1250. doi: 10.3390/diagnostics12051250.
4
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation.Preserflo微型分流器与Preserflo微型分流器及Ologen植入术的初步结果。
Eye Vis (Lond). 2021 Sep 3;8(1):33. doi: 10.1186/s40662-021-00253-3.
5
One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.难治性青光眼中独立 ab externo SIBS 微分流植入术的一年疗效。
Br J Ophthalmol. 2022 Jan;106(1):71-79. doi: 10.1136/bjophthalmol-2020-317299. Epub 2020 Oct 23.
6
XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results.XEN 凝胶支架与 PRESERFLO™ 微分流管植入治疗原发性开角型青光眼:两年结果。
Acta Ophthalmol. 2021 May;99(3):e433-e440. doi: 10.1111/aos.14602. Epub 2020 Sep 10.
7
Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C.新型独立式 Ab Externo SIBS 微分流控阀联合丝裂霉素 C 的中期疗效。
Am J Ophthalmol. 2020 Jul;215:141-153. doi: 10.1016/j.ajo.2020.02.020. Epub 2020 Mar 13.
8
Ab externo implantation of the MicroShunt, a poly (styrene--isobutylene--styrene) surgical device for the treatment of primary open-angle glaucoma: a review.用于治疗原发性开角型青光眼的聚(苯乙烯-异丁烯-苯乙烯)手术装置MicroShunt的外部植入:综述
Eye Vis (Lond). 2019 Nov 15;6:36. doi: 10.1186/s40662-019-0162-1. eCollection 2019.
9
Duration of surgery affects the risk of complications following total hip arthroplasty.手术时间的长短会影响全髋关节置换术后并发症的风险。
Bone Joint J. 2019 Jun;101-B(6_Supple_B):51-56. doi: 10.1302/0301-620X.101B6.BJJ-2018-1400.R1.
10
Prolonged operative duration is associated with complications: a systematic review and meta-analysis.手术时间延长与并发症相关:一项系统评价和荟萃分析。
J Surg Res. 2018 Sep;229:134-144. doi: 10.1016/j.jss.2018.03.022. Epub 2018 Apr 24.